ASPEN PHARMACR Balance Sheet - Annual (OTCMKTS:APNHY)

Add to My Stocks
$19.06 $0.68 (3.44%) APNHY stock closing price Jun 18, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our ASPEN PHARMACR stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the ASPEN PHARMACR stock analysis, and provides insights into the firm's financial performance. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. ASPEN PHARMACR balance sheet indicates an asset turnover ratio of and debt to equity ratio of . Also check ASPEN PHARMACR revenue and ASPEN PHARMACR operating cash flow for the same period.

View latest 10 year balance sheet data to check ASPEN PHARMACR financial performance.
show more
Fiscal year is Jul - Jun20172016
Cash786.45M756.46M
Marketable Securities--
Receivables999.6M818.92M
Inventory999.6M999.36M
Raw Materials301.35M249.84M
Work In Progress345.45M367.82M
Finished Goods352.8M381.7M
Notes Receivable--
Other Current Assets14.7M6.94M
Total Current Assets
2.8B2.58B
Property Plant & Equipment1.01B909.14M
Accumulated Depreciation294M235.96M
Net Property Plant & Equipment
712.95M673.18M
Investment & Advances--
Other Non-Current Assets--
Deferred Charges73.5M76.34M
Intangibles4.84B3.82B
Deposits & Other Assets117.6M83.28M
Total Assets
8.55B7.24B
Notes Payable--
Accounts Payable757.05M576.02M
Current Portion Long-Term Debt1.39B756.46M
Current Portion Capital Leases--
Accrued Expenses--
Income Taxes Payable--
Other Current Liabilities411.6M131.86M
Total Current Liabilities
2.56B1.46B
Mortgages--
Deferred Taxes/Income154.35M124.92M
Convertible Debt--
Long-Term Debt2.12B2.27B
Non-Current Capital Leases--
Other Long-Term Liabilities543.9M430.28M
Total Liabilities
5.38B4.29B
Minority Interest--
Preferred Stock--
Common Stock Net139.65M131.86M
Capital Surplus--
Retained Earnings2.37B1.97B
Treasury Stock--
Other Liabilities654.15M846.68M
Shareholders Equity3.17B2.95B
Total Liabilities & Shareholders Equity8.55B7.24B
All figures in USD. M: Millions of USD, B: Billions of USD.

Looking at ASPEN PHARMACR historical stock prices and the current ASPEN PHARMACR stock price can tell you how the stock price has moved, whereas the ASPEN PHARMACR PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the ASPEN PHARMACR company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. ASPEN PHARMACR had total assets of $8.55B.
  • Liabilities: This item on the balance sheet implies the firm's, in this case ASPEN PHARMACR's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for APNHY stock stand at $5.38B.

ASPEN PHARMACR Balance Sheet - Key Ratios